Corcept Therapeutics (CORT) Tops Q1 EPS by 12c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus
Go back to Corcept Therapeutics (CORT) Tops Q1 EPS by 12c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 114.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $114.47 | 52 Week High | $10.00 | |||
| Open | $114.47 | 52 Week Low | $3.22 | |||
| Day High | $114.47 | P/E | N/A | |||
| Day Low | $114.47 | EPS | $-0.46 | |||
| Volume | 1,862 | |||||
